Omni mini-LED sets feature a 4K QLED mini-LED display capable of delivering up to 1,400 nits of peak brightness, and support ...

The Valeda ® Light Delivery System (LumiThera, Inc.) is the first ever FDA-authorized treatment for vision loss in dry AMD, the manufacturer reported. The technology was evaluated in the LIGHTSITE III ...

We recently compiled a list of the 10 Best Metaverse Stocks To Buy According to Hedge Funds. In this article, we are going to ...

The Company also notes that Megan Baldwin, PhD, MAICD, retired from the Board as Executive Director, in accordance with ASX Listing Rules. Dr. Baldwin will continue to advance Opthea’s innovation ...

During the loading segment, subjects who have 20/80 vision or better and who satisfy other enrollment ... 825 subjects who are treatment-naïve or were diagnosed with wet AMD in the study eye within ...

Despite the introduction of therapies targeting VEGF, less than half of all treated patients with wet AMD, the most common ...

I am thrilled to further strengthen and enrich Ocular’s senior leadership team with the appointment of Namrata as Chief Business Officer. She brings a unique perspective to the role of CBO based on ...

Congress of the Asia-Pacific Vitreo-Retina Society, November 22 - 24, 2024Ophthalmology Innovation Summit XIV, November 23, 2024MELBOURNE, ...

The Food and Drug Administration will allow a new device to be marketed as a treatment for dry age-related macular degeneration.

The FDA announced marketing authorization of a form of light therapy as the first-ever treatment for dry age-related macular ...

A new study from researchers at Wilmer Eye Institute, Johns Hopkins Medicine explains not only why some patients with wet age ...

AMD CIO Hasmukh Ranjan has the company on the path to take full advantage of advances in artificial intelligence.